Core Laboratories Inc. (CLB)
NYSE: CLB · Real-Time Price · USD
16.77
-0.52 (-3.01%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Core Laboratories Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 526.52 | 523.85 | 509.79 | 489.74 | 470.25 | Upgrade
|
| Revenue Growth (YoY) | 0.51% | 2.76% | 4.09% | 4.14% | -3.49% | Upgrade
|
| Cost of Revenue | 417.59 | 420.52 | 399.96 | 393.66 | 367.9 | Upgrade
|
| Gross Profit | 108.93 | 103.33 | 109.83 | 96.08 | 102.36 | Upgrade
|
| Selling, General & Admin | 44.23 | 38.59 | 38.89 | 37.57 | 43.87 | Upgrade
|
| Amortization of Goodwill & Intangibles | 0.36 | 0.5 | 0.49 | 0.69 | 0.76 | Upgrade
|
| Other Operating Expenses | -1.66 | -2.32 | -1.81 | -1.71 | -1.32 | Upgrade
|
| Operating Expenses | 57.21 | 51.23 | 52.87 | 53.03 | 61.06 | Upgrade
|
| Operating Income | 51.72 | 52.1 | 56.97 | 43.05 | 41.3 | Upgrade
|
| Interest Expense | -10.57 | -12.37 | -13.43 | -11.57 | -9.15 | Upgrade
|
| Earnings From Equity Investments | -0.65 | 0.24 | 0.39 | 0.29 | 0.06 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.75 | -1.2 | -0.18 | -0.23 | 0.23 | Upgrade
|
| EBT Excluding Unusual Items | 39.75 | 38.77 | 43.75 | 31.55 | 32.44 | Upgrade
|
| Merger & Restructuring Charges | -2.96 | -2.79 | -2.29 | -3.33 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.81 | 1.78 | 0.2 | 1.07 | 1.44 | Upgrade
|
| Other Unusual Items | - | - | -0.46 | - | - | Upgrade
|
| Pretax Income | 45.9 | 46.19 | 41.21 | 29.95 | 36.11 | Upgrade
|
| Income Tax Expense | 15.51 | 14.03 | 4.18 | 10.3 | 15.89 | Upgrade
|
| Earnings From Continuing Operations | 30.39 | 32.15 | 37.03 | 19.66 | 20.22 | Upgrade
|
| Net Income to Company | 30.39 | 32.15 | 37.03 | 19.66 | 20.22 | Upgrade
|
| Minority Interest in Earnings | -0.72 | -0.75 | -0.35 | -0.21 | -0.49 | Upgrade
|
| Net Income | 29.67 | 31.4 | 36.68 | 19.45 | 19.73 | Upgrade
|
| Net Income to Common | 29.67 | 31.4 | 36.68 | 19.45 | 19.73 | Upgrade
|
| Net Income Growth | -5.51% | -14.38% | 88.53% | -1.39% | - | Upgrade
|
| Shares Outstanding (Basic) | 46 | 47 | 47 | 46 | 46 | Upgrade
|
| Shares Outstanding (Diluted) | 47 | 48 | 48 | 47 | 47 | Upgrade
|
| Shares Change (YoY) | -1.38% | 0.34% | 1.52% | 0.26% | 4.98% | Upgrade
|
| EPS (Basic) | 0.64 | 0.67 | 0.79 | 0.42 | 0.43 | Upgrade
|
| EPS (Diluted) | 0.63 | 0.66 | 0.77 | 0.42 | 0.42 | Upgrade
|
| EPS Growth | -4.54% | -14.29% | 83.40% | -0.04% | - | Upgrade
|
| Free Cash Flow | 22.44 | 43.36 | 14.21 | 14.74 | 23.04 | Upgrade
|
| Free Cash Flow Per Share | 0.48 | 0.91 | 0.30 | 0.32 | 0.49 | Upgrade
|
| Dividend Per Share | 0.040 | 0.040 | 0.040 | 0.040 | 0.040 | Upgrade
|
| Dividend Growth | - | - | - | - | -85.71% | Upgrade
|
| Gross Margin | 20.69% | 19.72% | 21.55% | 19.62% | 21.77% | Upgrade
|
| Operating Margin | 9.82% | 9.95% | 11.17% | 8.79% | 8.78% | Upgrade
|
| Profit Margin | 5.63% | 5.99% | 7.19% | 3.97% | 4.20% | Upgrade
|
| Free Cash Flow Margin | 4.26% | 8.28% | 2.79% | 3.01% | 4.90% | Upgrade
|
| EBITDA | 66.37 | 67.05 | 72.75 | 60.22 | 59.81 | Upgrade
|
| EBITDA Margin | 12.61% | 12.80% | 14.27% | 12.29% | 12.72% | Upgrade
|
| D&A For EBITDA | 14.65 | 14.95 | 15.78 | 17.16 | 18.52 | Upgrade
|
| EBIT | 51.72 | 52.1 | 56.97 | 43.05 | 41.3 | Upgrade
|
| EBIT Margin | 9.82% | 9.95% | 11.17% | 8.79% | 8.78% | Upgrade
|
| Effective Tax Rate | 33.78% | 30.39% | 10.15% | 34.37% | 44.01% | Upgrade
|
| Revenue as Reported | 526.52 | 523.85 | 509.79 | 489.74 | 470.25 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.